Richard A. Robson

3.6k total citations
87 papers, 2.8k citations indexed

About

Richard A. Robson is a scholar working on Nephrology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard A. Robson has authored 87 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 17 papers in Epidemiology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard A. Robson's work include Pharmacogenetics and Drug Metabolism (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Renal Diseases and Glomerulopathies (10 papers). Richard A. Robson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Renal Diseases and Glomerulopathies (10 papers). Richard A. Robson collaborates with scholars based in New Zealand, United States and Australia. Richard A. Robson's co-authors include John O. Miners, Stephen T. Chambers, Michael Lever, Donald Birkett, Michael E. McManus, Kelvin L. Lynn, David O. McGregor, Charlotte Hindsberger, Lisbeth V. Jacobsen and Milan Zdravković and has published in prestigious journals such as Hepatology, Kidney International and The American Journal of Medicine.

In The Last Decade

Richard A. Robson

84 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard A. Robson New Zealand	29	513	489	480	388	388	87	2.8k
Sophie L. Stocker Australia	28	476 0.9×	271 0.6×	509 1.1×	547 1.4×	311 0.8×	115	2.6k
Hassane Izzedine France	31	443 0.9×	735 1.5×	816 1.7×	763 2.0×	153 0.4×	103	4.1k
Eberhard Wieland Germany	38	911 1.8×	608 1.2×	1.2k 2.4×	364 0.9×	239 0.6×	132	4.6k
Otto Bekers Netherlands	31	412 0.8×	271 0.6×	459 1.0×	239 0.6×	183 0.5×	139	3.1k
Jérôme Biollaz Switzerland	41	297 0.6×	488 1.0×	1.2k 2.5×	643 1.7×	432 1.1×	155	6.1k
Gert A. Verpooten Belgium	34	763 1.5×	506 1.0×	616 1.3×	460 1.2×	156 0.4×	107	4.1k
Yoseph Caraco Israel	27	244 0.5×	322 0.7×	432 0.9×	337 0.9×	946 2.4×	102	2.3k
Shiro Ueda Japan	25	338 0.7×	291 0.6×	871 1.8×	157 0.4×	354 0.9×	111	2.7k
David Czock Germany	23	236 0.5×	377 0.8×	259 0.5×	226 0.6×	170 0.4×	111	2.3k
Keith G. Tolman United States	31	669 1.3×	803 1.6×	466 1.0×	300 0.8×	454 1.2×	83	3.2k

Countries citing papers authored by Richard A. Robson

Since Specialization

Citations

This map shows the geographic impact of Richard A. Robson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Robson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Robson more than expected).

Fields of papers citing papers by Richard A. Robson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Robson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Robson. The network helps show where Richard A. Robson may publish in the future.

Co-authorship network of co-authors of Richard A. Robson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Robson. A scholar is included among the top collaborators of Richard A. Robson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Robson. Richard A. Robson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hladunewich, Michelle, Michael L. McCaleb, Richard A. Robson, et al.. (2025). A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy. Kidney International. 109(3). 592–601.

Barbour, Sean, Michelle Hladunewich, Angela Makris, et al.. (2024). Phase II Results of an Investigational RNA Therapeutic to Complement Factor B, IONIS-FB-LRx, for Treatment of IgA Nephropathy. Journal of the American Society of Nephrology. 35(10S).

Barbour, Sean, Michelle Hladunewich, Angela Makris, et al.. (2022). An Exploratory Trial of an Investigational RNA Therapeutic, IONIS-FB-LRx, for Treatment of IgA Nephropathy. Journal of the American Society of Nephrology. 33(11S). 800–800. 4 indexed citations

Läwitz, E., Thomas Marbury, Beth J. Kirby, et al.. (2016). The Effect of Renal or Hepatic Impairment on the Pharmacokinetics of GS-9857, a Pan-Genotypic HCV NS3/4A Protease Inhibitor. Journal of Hepatology. 64(2). S613–S613. 2 indexed citations

Gibiansky, Leonid, Craig R. Rayner, Barbara J. Brennan, et al.. (2015). Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment. Journal of Pharmacokinetics and Pharmacodynamics. 42(3). 225–236. 10 indexed citations

Phelan, Mary C., Judith Anzures‐Cabrera, David Carlile, et al.. (2013). Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib. Clinical Pharmacokinetics. 52(4). 255–265. 10 indexed citations

Parrott, Neil, Dominik Hainzl, Daniela Alberati, et al.. (2013). Physiologically Based Pharmacokinetic Modelling to Predict Single- and Multiple-Dose Human Pharmacokinetics of Bitopertin. Clinical Pharmacokinetics. 52(8). 673–683. 15 indexed citations

Iwamoto, Marian, William D. Hanley, Amelia S. Petry, et al.. (2009). Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 53(5). 1747–1752. 37 indexed citations

Roberts, Stuart K., Graham Cooksley, Gregory J. Dore, et al.. (2008). Robust antiviral activity of R1626, a novel nucleoside analog. Hepatology. 48(2). 398–406. 87 indexed citations

10.

Macdougall, Iain C., Richard A. Robson, Sylvie Opatrná, et al.. (2006). Pharmacokinetics and Pharmacodynamics of Intravenous and Subcutaneous Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 1(6). 1211–1215. 143 indexed citations

11.

Agrawal, Nancy, Catherine Z. Matthews, Ralph S. Mazenko, et al.. (2003). Pharmacokinetics of Etoricoxib in Patients with Renal Impairment. The Journal of Clinical Pharmacology. 44(1). 48–58. 32 indexed citations

12.

McGregor, David O., et al.. (2002). Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney International. 61(3). 1040–1046. 67 indexed citations

13.

McGregor, David O., et al.. (2001). Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney International. 59(6). 2267–2272. 82 indexed citations

14.

Chambers, Stephen T., et al.. (2001). Glycine betaine excretion is not directly linked to plasma glucose concentrations in hyperglycaemia. Diabetes Research and Clinical Practice. 52(3). 165–169. 9 indexed citations

15.

McGregor, David O., Adrian L. Buttimore, Richard A. Robson, et al.. (2000). Thirty years of universal home dialysis in Christchurch.. PubMed. 113(1103). 27–9. 24 indexed citations

16.

Bailey, Ross R., et al.. (1997). OKT3 for the Treatment of Steroid-Resistant Acute Renal Allograft Rejection. Nephron. 77(3). 298–303. 8 indexed citations

17.

Sizeland, Peter, et al.. (1995). Short-term response of nonurea organic osmolytes in human kidney to a water load and water deprivation. American Journal of Physiology-Renal Physiology. 268(2). F227–F233. 13 indexed citations

18.

Shand, Brett, Adrian L. Buttimore, Kelvin L. Lynn, Ross R. Bailey, & Richard A. Robson. (1994). Effect of Hemodialysis and Recombinant Human Erythropoietin on Determinants of Blood Viscosity. Renal Failure. 16(3). 407–413. 13 indexed citations

19.

Robson, Richard A., John O. Miners, Andrew Matthews, et al.. (1988). Characterisation of theophylline metabolism by human liver microsomes. Biochemical Pharmacology. 37(9). 1651–1659. 113 indexed citations

20.

McManus, Michael E., Pauline de la Μ. Hall, Ieva Stupans, et al.. (1987). Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.. PubMed. 32(1). 189–94. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact